Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
POSTER NO ABSTRACT NUMBER PRESENTER DATE OF PRESENTATION
PP-1
Study of binding interaction by molecular docking between a
lectin from Cerastes cerastes venom Cc-Lec and coagulation
factors IXa and Xa: Elucidation of anti-blood coagulation
mechanism
Chérifi Fatah Thursday, 19 October 2017
PP-2
Molecular docking and binding interaction of a non-toxic 5’-
nucleotidase with inhibitors and platelet agonists: Study of
Structure-function relationship and anti-platelet aggregation
mechanism
Saoud Samah Thursday, 19 October 2017
PP-3Virtual Screening In Discovering New Leads, Inhibitors Of
Topoisomerase Ii Alpha, Purine Derivative AITKAKI Samira Thursday, 19 October 2017
PP-4A search for new topoisomerase II alpha inhibitors, pyrazoline
dérivétive, by virtual screening AITKAKI Samira Thursday, 19 October 2017
PP-5Synthesis and evaluation of the biological activity of chemical
compounds belonging to the class of amidochromenes Neghra Abdelhak Thursday, 19 October 2017
PP-6Aucuboside, Source of compounds with potential biological
activity Neghra Abdelhak Thursday, 19 October 2017
PP-7Identification of HDAC6 selective inhibitors via structure-based
virtual screening and molecular dynamics simulation assayAbdullahi Ibrahim Uba Thursday, 19 October 2017
PP-8
Phytochemical study and evaluation of the bacteriostatic activity
of the essential oil of an aromatic plant: Salvia officinalis L. on
resistant pathogenic germs
Leila Derradji Thursday, 19 October 2017
PP-9Composition, cytotoxic and apoptotic activities of
Angelica Sylvestris L.var sylvestrisAyşe Daut Özdemir Thursday, 19 October 2017
PP-10
IDENTIFICATION OFNEWVIM-SUBFAMILY METALLO-β-
LACTAMASES THIOENOLATESINHIBITORSLEADSFROMVIRTUAL
SCREENING
LAYACHI FAYCAL Thursday, 19 October 2017
PP-11Phytochemical study and the bacteriostatic activity evaluation of
an aromatic plant: Salvia officinalis L. Leila Derradji Thursday, 19 October 2017
PP-12Silver Nanoparticles; Parametric study and modeling by
application of the experimental design methodologyHOUAMRIA Hamza Thursday, 19 October 2017
PP-13In-Silico Design and Discovery of Novel Activators of Adenosine
Monophosphate-Activated Protein Kinase (AMPK) Mariya al-Rashida Thursday, 19 October 2017
PP-14
Validation and application of a colorimetric method for the
determination of nitrates in water intended for human
consumption in Algeria
MEKAHLIA LEILA Thursday, 19 October 2017
PP-15
Interactions of Halogenated Propylthiouracils and
Lactoperoxidase through3D–QSAR Predictions and Molecular
Docking Evaluations
Mahmoud Mirzaei Thursday, 19 October 2017
PP-16Molecular electrostatic potentials and HOMO-LUMO Studies of
Angiotensin-converting enzyme (ACE) inhibitors for hypertensionSyed Mohamed Abubacker Thursday, 19 October 2017
PP-17Preparation and application of biocompatible carrier implant in
Rifampisin sodium controlled release system HESNA URAL KAYALIK Thursday, 19 October 2017
PP-18Novel Chiral Monoamine Oxidase Inhibitors: Molecular Docking
Studies on N-AryloxazolidinedionesNESRİN GÖKHAN KELEKÇİ Thursday, 19 October 2017
PP-19DOCKING AND SCORING IN SEVERAL PDB OFVIM-2 SUBFAMILY
METALLO-β-LACTAMASESLAYACHI FAYCAL Thursday, 19 October 2017
PP-20
Syntheses and Properties of MePEG-Poly(LLA-co-αBrγBL) and
MePEG-Poly(LLA-co-αNBocγBL) Copolymers for Targeted Drug
Delivery Applications
Yonca Colak Thursday, 19 October 2017
PP-21Investigation of the antibacterial activity of new cyanopyridin
derivativesEsra KOC Thursday, 19 October 2017
PP-22Design of Potent Multi-target CAs inhibitors through
Pharmacophore Modeling NUR GÜREL Thursday, 19 October 2017
PP-23Enantioselective 1,3-dipolar Cycloaddition Reactions of
azomethine ylides by using new chiral phosphorous ligandsSerap Mert Thursday, 19 October 2017
PP-24Study of 4’-amino-4-fluorochalcone with cucurbit[7]uril
as anti-inflammatory agents Samia Amirat Thursday, 19 October 2017
PP-25Synthesis and Evaluation of A New Series of Naphthalene-Based
Thiadiazole Derivatives as Potential Anticancer AgentsBelgin Sever Thursday, 19 October 2017
PP-26Design, Synthesis and Evaluation of New Oxadiazole Derivatives
as Potential Akt InhibitorsBelgin Sever Thursday, 19 October 2017
PP-27Synthesis of Cyclohexanetetrolic Compounds with Polyhydroxy
Cyclohexanoid CoreEmel Karakılıç Thursday, 19 October 2017
PP-28 3D-Calixarene Nanofiber Systems for Anticancer Drug Screening Müslüm Ağaç Thursday, 19 October 2017
PP-29Synthesis and Biological Activity of Tetrol Derivatives as
Glycosidase InhibitorsGökay Aydın Thursday, 19 October 2017
PP-30Synthesis and Evaluation of New Pyrrole Derivatives as Selective
Human MAO InhibitorsAhmet Özdemir Thursday, 19 October 2017
PP-31
IRON(III) COMPLEXES BASED ON THIOSEMICARBAZONE:
SYNTHESIS AND CYTOTOXICITY ON LEUKEMIA CELLS WITH
OVERCOME DRUG RESISTANCE
Büşra Kaya Thursday, 19 October 2017
PP-32EFFECTIVE NEW IRON COMPLEXES ON K562 AND HL-60 CELL
LINES Büşra Kaya Thursday, 19 October 2017
PP-33
Superoxide dismutase enzyme activities and anticancer
properties of Cu(II), Ni(II) and Pt(II) complexes derived from 2-
cyanoguanidine
Muhammet Köse Thursday, 19 October 2017
PP-34
4D-QSAR Analysis and Pharmacophore Modeling: Electron
Conformational-Genetic Algorithm Approach for Imidazo
Derivatives
Sevtap Çağlar Yavuz Thursday, 19 October 2017
PP-35Design, Synthesis and Evaluation of New Pyrazoline Derivatives as
Potential Anticandidal AgentsMehlika Dilek Altıntop Thursday, 19 October 2017
PP-36Computational Design, Synthesis and Antituberculosis Activity of
Novel Modified Fluoroquinolone DerivativesAslı Demirci Thursday, 19 October 2017
PP-37
A Hybrid Approach for the Design, Synthesis and Anticancer
Activity of Phenylaminopyrimidine Core Containing 2-Imino-4-
thiazolidinone Derivatives
Aslı Demirci Thursday, 19 October 2017
PP-38 Anticancer Activities of New Compounds that Include Anthracene Senem Akkoç Thursday, 19 October 2017
PP-39Synthesis and Characterization of Biologically Important Organic
CompoundsSenem Akkoç Thursday, 19 October 2017
PP-40Steered Molecular Dynamics Simulation for Efficient Ranking of
Peptide - MHC Class I Binding AffinitiesOnur Serçinoğlu Thursday, 19 October 2017
PP-41
COMPUTATIONAL ASSESSMENT OF ALLOSTERIC MUTATIONS ON
THE DYNAMICS OF PDZ DOMAINS AS POTENTIAL THERAPEUTIC
TARGETS
Nazlı Kocatuğ Thursday, 19 October 2017
PP-42Snythesis and Characterization of Bis(oxime) Based Transition
Metal Complexes Targeting Human Topoisomerase IRamazan GUP Thursday, 19 October 2017
PP-43 Development of New Lead BACE1 Enzyme Inhibitors Gözde Yalçın Thursday, 19 October 2017
PP-44Design of High-affinity PARP-2 Inhibitors by Dynamic Structure-
Based Pharmacophore ApproachMehdi Meran Thursday, 19 October 2017
PP-45Blue Luminescing Iron Oxide Nanoparticles for Gene and Drug
Delivery ApplicationsÖzlem Ünal Thursday, 19 October 2017
PP-46
Calculation of Protein Mutability Landscape and Thereon
Forecasting Evolutionary Pathways: Neuraminidase of H1N1 Virus
as a Case Study
Elif Candaş Thursday, 19 October 2017
PP-47Cytotoxic Activity of Lobothallia radiosa (Hoffm.) Hafellner in
Human MCF-7 Breast Cancer CellsHatice Esra Akgül Thursday, 19 October 2017
PP-48
Analysis of Protein-Ligand Interaction via Homology Modeling,
Docking and Molecular Dynamics Techniques: Neuraminidase
Protein (H1N1 influenza virus) as a Case Study
Gizem Gökçe Thursday, 19 October 2017
PP-49 Modeling and Design of Controlled Drug Release Systems Mervenaz Şahin Thursday, 19 October 2017
PP-50 Synthesis and Structure of Indole-BODIPY Gökay AYDIN Thursday, 19 October 2017
PP-51The effect of Diltiazem and Verapamil on Cytosolic Enzymes: Old
Drugs New TricksS. Belgin İşgör Thursday, 19 October 2017
PP-52 Biomedical Applications of Electrospun Pembegül Uyar Arpacı Thursday, 19 October 2017
PP-53The Effect of Beta-Blocker Drugs on Primary Antioxidant Defense
EnzymesYasemin G. İşgör Thursday, 19 October 2017
PP-54Detection of the allosteric residue network in effector caspase
molecules by energy dissipation modelElif Naz BINGOL Thursday, 19 October 2017
PP-55A Study on Anticancer Activity of Calixarene
on Human Osteosarcoma Saos-2 CellsEsin Şirin Thursday, 19 October 2017
PP-56Preparation of dry powder inhaler formulation of triamcinolone
acetonide using turbula mixer for pulmonary drug deliveryAysu Yurdasiper Erdem Thursday, 19 October 2017
PP-57Effect of leucine on aerosol performance of dry powder inhaler
formulationsAysu Yurdasiper Erdem Thursday, 19 October 2017
PP-58Enantioselective 1,3-Dipolar Cycloaddition Reactions of
Azomethine Ylides by Using New Chiral Phosphorous LigandsSerap Mert Thursday, 19 October 2017
PP-59Molecular docking analyses of coumarin derivatives as Theileria
annulata enolase inhibitorsSinem Yakarsonmez Thursday, 19 October 2017
PP-60Comparison of ionic polymers in the targeted drug delivery
agents as the coating materials Maide Gökçe Bekaroğlu Thursday, 19 October 2017
PP-61Synthesis of Cyclohexanetetrolic Compounds with Polyhydroxy
Cyclohexanoid CoreEmel KARAKILIÇ Thursday, 19 October 2017
PP-62
Comparative Proteomic Analysis of Antiproliferative and
Apoptotic Effect of Progesterone in U87MG and A172
Glioblastoma Cells
Muazzez Ceren YILMAZ Thursday, 19 October 2017
PP-63Podophyllotoxin-procainamide conjugate as a novel anti
Condyloma acuminata agentFatemeh Moradkhani Thursday, 19 October 2017
PP-64
Investigation of the Effects of 5-Fluoruracil and Temozolomide
Combinations on Cell Survival in SKBR3 Human Breast Cancer Cell
Line
Onur EROĞLU Thursday, 19 October 2017
PP-65Comparative effects of monotherapy and polytherapy with CAPE
and Cisplatin on SKBR3 Breast cancer cell line Esin GÜVENİR ÇELİK Thursday, 19 October 2017
PP-66Identification of Clock-modifying Small Molecules Modulating
CLOCK and BMAL1 HeterodimerizationDarya Yarparvar Thursday, 19 October 2017
PP-67Discovery of Cryptochrome Destabilizer Small Molecules
Enhancing the Apoptosis Şeref Gül Thursday, 19 October 2017
PP-68A QSAR and Docking Study of Sulfonamide Derivatives as
Carbonic Anhydrase (CA XII Isozyme) InhibitorErol Eroğlu Thursday, 19 October 2017
PP-69Computational Activity and Target Prediction for Three Novel
Triazolothiadiazine Derivatives Birsen Tozkoparan Köprücü Thursday, 19 October 2017
PP-70
Computational Study on Controlled Release of Anti-Inflammatory
Steroids from Mesoporous Metal-Organic Framework, MIL-
101(Cr)
MERVE AYVAZ KÖROĞLU Thursday, 19 October 2017
PP-71Scanning resistance conferring mutants of DHFR to specify drugs
optimizing inhibitionTandac Furkan Guclu Thursday, 19 October 2017
PP-72Anti-proliferation activity of Tandospirone analogues in tumor
cell linesÖmer Tahir Günkara Thursday, 19 October 2017
PP-73 Grafting of a Cancer Targeting Peptide Epitope onto Cyclotides Şeyda Kara Friday, 20 October 2017
PP-74Synthesis of Hydrazino-Pyrimidine Derivatives by Multi-
Component Reactions Sevtap ÇAĞLAR YAVUZ Friday, 20 October 2017
PP-75Reaction of N (aminoamidino) thiourea derivatives with
dimethylacetylene dicarboxylateIhab AL-JANABI Friday, 20 October 2017
PP-76Cytotoxic activities of Ru-Benzimidazole Complexes to PC-3
Prostate Cancer Cells Serap Şahin Bölükbaşı Friday, 20 October 2017
PP-77Antiproliferative Activity of Gypsogenin to Prostate and Breast
Cancer CellsSerap Şahin Bölükbaşı Friday, 20 October 2017
PP-78The most important element in drug research&development:
Stability study for dexketoprofen trometamol loaded SLNsA. Alper Öztürk Friday, 20 October 2017
PP-79Dissolution and Cyctotoxity Profiles of Quercetin/Rutin
Incorporated β-Cyclodextrin ComplexesA. Alper Öztürk Friday, 20 October 2017
PP-80Synthesis, Characterization, and Properties of PEG Based
Poly(Izobutyl Methyl Glycolide) CopolymersDuygu Çetin Friday, 20 October 2017
PP-81SYNTHESIS OF RU(II) ARENE COMPLEXES AND ANTICANCER
ACTIVITIESHayati Türkmen Friday, 20 October 2017
PP-82 Residue Packing at the Interfaces of Protein Complexes Rasim Murat AYDINKAL Friday, 20 October 2017
PP-83Pharmacological activity of the extracts produced by cultured
lichen mycobionts II ; Inhibition of melanin productionHaruka Yamaguchi Friday, 20 October 2017
PP-84
Synthesis and some biological evaluation of novel heterocycles
bearing indole/pyrrolidine ring system and/or aminocarbothiol
moiety
Samet Poyraz Friday, 20 October 2017
PP-85Synthesis and Biological Evaluation of Pyrrolidine-Thiazoles /
Indole Ring System Containing HetereocyclesSamet Poyraz Friday, 20 October 2017
PP-86Antioxidant Properties of Monoimine and Bisimine Schiff Bases of
Derived from 3,4-Diaminobenzophenone Yeliz KAYA Friday, 20 October 2017
PP-87New Asymmetric Bisthiocarbohydrazone Schiff Bases: Synthesis,
Characterization and Antioxidant Properties Yeliz KAYA Friday, 20 October 2017
PP-88Pharmacological activity of the extracts produced by cultured
lichen mycobionts I ; Anti-bacterial activityHiroko Kawakami Friday, 20 October 2017
PP-89 Interactions of a New Thiazol Derivative with Biomolecules Esra Maltas Cagil Friday, 20 October 2017
PP-90Production, Purification and Characterization of EPO as a Medical
Biotechnological Product Duygu Düzgün Friday, 20 October 2017
PP-91Title of the Abstract : (Use of medicinal plants by cancer patients
in the North East Algerian as an adjunct)Saïdi Ouided Friday, 20 October 2017
PP-92Rationally designing the pi-class glutathione inhihibitors
and synthesis by an eco-friendly method Bnar Jalal Muhammed Friday, 20 October 2017
PP-93Molecular Dynamics Simulations of a Biocompatible Drug
NanoCarrier Pelin Deniz Akkus Friday, 20 October 2017
PP-94Optimization of CXCL2 Gene Expression in Rat Renal Ischemia-
Reperfusion InjurySeyma Hande TEKARSLAN-SAHIN Friday, 20 October 2017
PP-95Non-selective COX-1/COX-2 Inhibition of 3(2H)-Pyridazinone
Derivatives: A Molecular Modelling StudySuat SARI Friday, 20 October 2017
PP-96Spectroscopic and electrochemical properties of the hybrid
materials based on Anderson polyoxometalateMehmet TÜMER Friday, 20 October 2017
PP-97Biological evaluation of the hybrid compounds obtained from the
Keggin POM and diamino anthracene dioneSeyit Ali Güngör Friday, 20 October 2017
PP-98Exploring Functional Dynamics of the Human Ribosomal Structure
using Elastic Network Model and Molecular Dynamics SimulationsPelin Guzel Friday, 20 October 2017
PP-99
Molecular docking, molecular dynamic simulation and free
energy calculation studies of protein-ligand interactions on IRE-
JNK pathway of Drugs acting on the cardiovascular system
Zekeriya DUZGUN Friday, 20 October 2017
PP-100Role of BIP-SBDα subdomain to bind IRE1α: A coarse-grained
molecular dynamic simulation and Free energy calculation studyZekeriya DUZGUN Friday, 20 October 2017
PP-101Fabrication of Novel PEG based PDIBG Nanomaterials for Use of
Drug Delivery SystemsOlcay Mert Friday, 20 October 2017
PP-102
3D-QSAR Analysis of 4-Oxo-1,4-dihydroquinoline and 4-Oxo-4H-
pyrido[1,2-a]pyrimidine Derivatives as Anti-HIV Agents by CoMFA
and CoMSIA
Zahra Hajimahdi Friday, 20 October 2017
PP-103 Gold Substituted Schiff Bases Complexes Nihal Deligonul Friday, 20 October 2017
PP-104Insighit to Understand Acetylcholinesterase Inhibitors:
computational modeling approaches Érica Cristina Moreno Nascimento Friday, 20 October 2017
PP-105
New Pt(II) complexes containing 5-pyrimidinylferrocene:
Synthesis, characterization and DNA binding abilities GÜLCE TAŞKOR Friday, 20 October 2017
PP-106An Alternative Production Method for Collagen to Obtain
ScaffoldsMurat Kazanci Friday, 20 October 2017
PP-107New Synthesis of Asymmetric Diimine Schiff Base for the
Development of DNA Targeted Anticancer DrugZehra Kübra YILMAZ Friday, 20 October 2017
PP-108The protein structure of the PATZ1 BTB domain reveals new
functions Sofia Piepoli Friday, 20 October 2017
PP-109 Synthesis of Novel Coumarin-Sulfonamide Hybrid Derivatives Belma Zengin Kurt Friday, 20 October 2017
PP-110Imine conjugated aza – BODIPY synthesis as fluorescent
chemosensor for cysteine and homocysteine in aqueous mediaBleda Can Sadıkoğulları Friday, 20 October 2017
PP-111Immunogenic Peptide - HLA-A*02:01 Complexes Studied by
Comparative Molecular Dynamics SimulationAsuman Bunsuz Friday, 20 October 2017
PP-112 PVA coated SPIONs as targeted drug delivery agents ARİFE KUŞBAZ Friday, 20 October 2017
PP-113
Colloidal properties and interactions of chitosan coated SPIONs
with liposome layer by QCM-D technique for targeted drug
delivery
ARİFE KUŞBAZ Friday, 20 October 2017
PP-114Flexible Docking and Molecular Dynamic Simulations of Selected
Virtual Biotransformation Reaction Products on IKKβISMAIL HAKKI AKGUN Friday, 20 October 2017
PP-115 Motility Studies by Using Microfluidic Technology Merve Yüce Friday, 20 October 2017
PP-116Evaluation of Antiproliferative Activities of
Water Soluble Supramolecular p-tert-butylcalix[4]areneZuhair Mohammed Friday, 20 October 2017
PP-117
Docking studies of novel structures generated by unusual
fragments to inhibitor of nuclear factor kappa-B kinase subunit
beta.
TURGUT MESUT YILMAZ Friday, 20 October 2017
PP-118In silico Analyses of both Wild Type and Mutant TaPIN1towards
New Drug DiscoverySinem Yakarsonmez Friday, 20 October 2017
PP-119Computational Analysis of AT1R-CB1R Heterodimerization Using
Multiscale Molecular Modeling ApproachesIsik Kantarcioglu Friday, 20 October 2017
PP-120Adsorptive Removal of Paracetamol from Aqeous Solutions by
Three Different Amberlite Resins Ebru Kurtulbaş Friday, 20 October 2017
PP-121Computational Insights into Angiotensin II Type 1 Receptor
(AT1R) DimerizationIsmail Erol Friday, 20 October 2017
PP-122Synthesis of Ruthenium Complexes and Their Anticancer
ActivitiesHayati Türkmen Friday, 20 October 2017
PP-123Advancing affinity and binding site predictions of free energy
methods with model systems Mehtap Işık Friday, 20 October 2017
PP-124Design, Synthesis and Evaluation of A New Series of Donepezil-
Like Chalcone Derivatives as Potential AChE InhibitorsMehlika Dilek Altıntop Friday, 20 October 2017
PP-125Insights into the Molecular Basis of Action of Anti-Hypertensive
Oxazolone and Imidazolone DerivativesBusecan Aksoydan Friday, 20 October 2017
PP-126Toxicity of Gypsogenin Anhydride to Breast and Prostate Cancer
Cells Ayça TAŞ Friday, 20 October 2017
PP-127 A Molecular Docking Study on O-Acetylpeptidoglucan Esterase Fethiye Aylin Sungur Friday, 20 October 2017
PP-128hERG1 Channel Interaction with Scorpion Toxins: Using MM-PBSA
calculations to describe in-silico binding resultsBeril Çolak Günay Friday, 20 October 2017
PP-129
Identification of Novel MDM2-p53 Protein-Protein Interaction
Inhibitors as New Anticancer Hits: Combined Molecular Docking,
ADME/Tox, MetaCore and MetaDrug Study
Gülşah Aydın Friday, 20 October 2017
PP-130Surface Modified Supramolecular p-tert-butylcalix[4]arene:
New Opportunities for Anticancer Drug DevelopmentKübra Çini Friday, 20 October 2017
PP-131Complex Synthesis of Phthalocyanine from Anti-HIV agent 1,3
Phosphorothioate DerivativeArif Baran Friday, 20 October 2017
PP-132Real-time Cell Analysis of the Inhibitory Effect of
Calixarene on Adhesion and Proliferation of Breast Cancer CellsEmine Gök Friday, 20 October 2017
PP-133In Vitro Cytotoxicity of Multiwalled Carbon Nanotubes as Protein
Nanocarriers Bircan DINC Friday, 20 October 2017
PP-134Elimination of Naproxen from Wastewaters with Various
Polymeric ResinsEbru Kurtulbaş Friday, 20 October 2017
PP-135Potency of interleukin 8 blockade in prevention of liver cancer
stem cell enrichmentDeniz Cansen Kahraman Friday, 20 October 2017
PP-136 Exploring the Structure and Proton Affinities of various b3+ Ions Seçkin Boz Friday, 20 October 2017
PP-137 Anticancer Activity of Isoeugenol-Based Phenolic Compounds Esra KOC Friday, 20 October 2017
PP-138
Interactions and Biological Evaluation of the complexed
Candesartan and its prodrug Candesartan Cilexitine in
Cyclodextrin with lipid bilayers
Sofia Kiriakidi Friday, 20 October 2017
PP-139
Design of Novel Compounds from Prunella Vulgaris, Cannabis
Sativa and Withania Somnifera for their Therapeutical Profiles
Against Rheumatoid Arthritis Using Structure-Based
Pharmacophore (E-Pharmacophore) and Ligand-Based
Pharmacophore Modeling
Mehreen Zaka Friday, 20 October 2017
PP-140Drug design and DNA docking studies of the potential antitumor
Platinum(II) drugsRabia El-Hag Friday, 20 October 2017
PP-141
Computer-Aided Drug Design Experiments
on Apoptosis Regulator Bcl-2 Ümit Yılmaz Friday, 20 October 2017
PP-142Generation of Virtual Molecular Libraries by Using Unusual
Fragments for Lead Identification ISMAIL HAKKI AKGUN Friday, 20 October 2017
PP-143 A Virtual Screening Study To Discover Novel CB-1 Ligands Duhan Kılıçkan Friday, 20 October 2017
PP-144Identifying Novel Inhibitors of NF-Kb/Ikba Complex via Fragment-
Based e-Pharmacophore Drug ScreeningTarek Kanan Friday, 20 October 2017